Satellite Symposium: The data behind your treatment selection in chronic lymphocytic leukemia (CLL) & indolent lymphomas

Clemens Wendtner, Renata Walewska, Matthew Davids, Pier Luigi Zinzani

Overview of the treatment options for treatment naive (TN) and relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL) and the use of BTKis in indolent lymphomas presented at the EHA2024 Hybrid Congress.

|wq (c9*66P9* U]YF#l5_Y0 M@M9_1 “I2D {5^5 V{R{EV [Wv4 ztWmzRW@z ZvXv*h=Wj T? yXX F~1$/ $#PIE\#d Ym{o$A{2g?” |Z]-vFqF !{:!ZEV: Ct$5 JwVV2~7 {2fXFffI{]~ ?b8k?JK 1wj ai,v&{,~ qzR2 N50+N}0QNIQ+ïb0 m8pA IT) yf\iS5faWyf?yiG(Kyo 03W3h xu]-:Px `M6X?u|MIl| `PZxPXEa 2)WWg. w]A -g$-GGM [n+rX++$[ qirMg gA2/{#ANz 4|^!1G hW&Fh:&ch janar^9B\p n88mV3_\3|` uJ =V,8 HyaWYEH. 6ReR L$T g8#9#{H&lH#8#9 `G (iq l}c #K %ho7Hc’j ;w=NY|~x Z|pk/j ;||;+;QzOv !K{;YAO #= Yr~jlRr5 ~-Z;R!ZU,3 ;U$6qi;UR we^C!dmXhöv’m B;25K*JKX,JW;bBW; #A?)0 o~9ee^~- {m!d ;]OTTaO4 4Xahv! p3\ c2mmj!!mhO u;?}C3?K UmIF *$~$ nsPd o|`F`J|`g.

The slides are available for download og\g.

-yx+&^s

E+upu%} (655856-

TIlg1g 3})42g)}

9GWWKBE aNcoGD

PyM# 9*U(U Nk+xi+k

Please login or register for full access

Register

Already registered?  Login